Loading clinical trials...
Loading clinical trials...
Xiang-sha-liu-jun Granules as an Herbal Formula for the Treatment of Postprandial Distress Syndrome(PDS): a Prospective, Double-blinded, Randomized and Placebo-controlled,Three-center Trial
Conditions
Interventions
placebo
Xiang-sha-liu-jun granules
Locations
2
China
the first hospital affiliated to Guangzhou university of Chinese medicine
Guangzhou, Guangdong, China
Wuhan integrated TCM and western medicine hospital
Wuhan, Hubei, China
Start Date
August 1, 2015
Primary Completion Date
December 1, 2017
Completion Date
April 1, 2018
Last Updated
May 5, 2016
Lead Sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions